Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$7.38 - $10.4 $1.53 Million - $2.15 Million
206,800 Added 478.7%
250,000 $1.88 Million
Q1 2021

May 13, 2021

SELL
$10.34 - $12.81 $2.14 Million - $2.65 Million
-206,800 Reduced 82.72%
43,200 $499,000
Q4 2020

Feb 09, 2021

SELL
$8.61 - $11.04 $1.72 Million - $2.21 Million
-200,000 Reduced 44.44%
250,000 $59,000
Q1 2020

May 14, 2020

BUY
$6.69 - $13.45 $3.01 Million - $6.05 Million
450,000 New
450,000 $210,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.